Mostrando las entradas con la etiqueta 2009 flu pandemic. Mostrar todas las entradas
Mostrando las entradas con la etiqueta 2009 flu pandemic. Mostrar todas las entradas

31 mayo, 2013

Natural inmunity against A/H1N1 2009 ( flu virus )

English: Swineflu cases in the UK (HPA modelling)
English: Swineflu cases in the UK (HPA modelling) (Photo credit: Wikipedia)

 In spite of many evidence support that the flu vaccine is not effective, this article focus also in the natural inmunity against the A/N1H1, where in cities like London the number climbs to 70% of the population who has natural antibodies against these virus. So, the question is......why the CDC and WHO persist in these kinds of policies, where the only who win something is Big Pharma ?

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

Full Text

Source

Centre for Infections, Health Protection Agency, London, UK.

Abstract

OBJECTIVES:

The objectives of the H1N1 2009 serological surveillance project were twofold: to document (1) the prevalence of cross-reactive antibodies to H1N1 2009 by age group in the population of England prior to arrival of the pandemic strain virus in the UK and (2) the age-specific incidence of infection by month as the pandemic progressed by measuring increases in the proportion of individuals with antibodies to H1N1 2009 by age.

METHODS:

Residual aliquots of samples submitted to 16 microbiology laboratories in eight regions in England in defined age groups in 2008 and stored by the Health Protection Agency serological surveillance programme were used to document age-stratified prevalence of antibodies to H1N1 2009 prior to the arrival of the pandemic in the UK. Functional antibodies to the H1N1 2009 virus were measured by haemagglutination inhibition (HI) and microneutralisation (MN) assays. For timely measurement of monthly incidence of infection with H1N1 2009 between August 2009 and April 2010, the microbiology serum collections were supplemented by collection of residual sera from chemical pathology laboratories in England. Monthly seroincidence samples were tested by HI only, apart from the final sera collected post pandemic in 2010, which were also tested by MN. Incidence during the pandemic was estimated from changes in prevalence between time points and also by a likelihood-based method.

SETTING:

Eight regions of England.

PARTICIPANTS:

Serum samples from patients accessing health care in England from whom blood samples were taken for unrelated microbiological or chemical pathology testing.

INTERVENTIONS:

None.

MAIN OUTCOME MEASURES:

Baseline age-specific prevalence of functional antibodies to the H1NI 2009 virus prior to the arrival of the pandemic; changes in antibody prevalence during the period August 2009 to April 2010.

RESULTS:

Pre-existing cross-reactive antibodies to H1N1 2009 were detected in the baseline sera and increased with age, particularly in those born before 1950. The prediction of immunological protection derived from the baseline serological analysis was consistent with the lower clinical attack rates in older age groups. The high levels of susceptibility in children < 15 years, together with their mixing within school, resulted in the highest attack rates in this age group. Serological analysis by region confirms that there were geographical differences in timing of major pandemic waves. London had a big first wave among the 5- to 14-year age group, with the rest of the country reducing the gap after the second wave. Cumulative incidence in London remained higher throughout the pandemic in each age group. By the end of the second wave it is estimated that as many as 70% of school-aged children in London had been infected. Taken together, these observations are consistent with observations from previous pandemics in 1918, 1957 and 1968 - that the major impact of influenza pandemics is on younger age groups, with a pattern of morbidity and mortality distinct from seasonal influenza epidemics.

CONCLUSIONS:

Serological analysis of appropriately structured, age-stratified and geographically representative samples can provide an immense amount of information to set in context other measures of pandemic impact in a population, and provide the most accurate measures of population exposure. National scale seroepidemiology studies require cross-agency coordination, multidisciplinary working, and considerable scientific resource.

FUNDING:

The National Institute for Health Research Health Technology Assessment programme and the Health Protection Agency.
Enhanced by Zemanta

14 enero, 2012

Gripe en España

English: Map of Spain with Navarre highlighted...Image via Wikipedia
Pamplona, 13 ene (EFE).- Los casos de gripe estacional han repuntado en Navarra en la primera semana de enero, si bien se sitúan lejos del umbral epidémico, según el último informe semanal de la Red de Médicos Centinela para la Vigilancia de la Gripe en Navarra.
El informe, según informa el Ejecutivo foral en una nota, indica que se ha registrado en Navarra una tasa de síndromes gripales de 29,6 casos por 100.000 habitantes, lo que representa un incremento respecto a la anterior, fijada en 26,3, aunque se sitúa lejos del umbral epidémico establecido en 65 casos por 100.000 habitantes.
Por otro lado, la Red de Médicos Centinela para la vigilancia de la gripe en Navarra ha procesado en esta semana siete muestras, de las que cuatro han resultado positivas a gripe AH3.
Asimismo, se mantiene elevado el número y porcentaje de niños atendidos en el hospital que se han confirmado para virus respiratorio sincitial.
Por su parte, el lunes 9 de enero, tras concluirse las festividades navideñas, se detectó un aumento del número de consultas por síndrome gripal en atención primaria.
Las mismas fuentes informan de que la página web del Gobierno de Navarra incluye un apartado en el que se facilita al ciudadano información sobre la gripe, como preguntas frecuentes, qué hacer en caso de enfermedad o medidas preventivas. EFE

Enhanced by Zemanta

10 abril, 2011

Un documento para tener en cuenta

The various strains of influenza that have inf...Image via Wikipedia
Este articulo llego a mi mail, como cientos de mails recibidos sobre conspiraciones y negocios en la pandemia que la OMS declaró en Junio de 2009.  No abona teorias conspirativas, si no más bien sobre preguntas que nos hemos hecho muchas veces durante estos meses, y más aun, con la llegada del pico de la pandemia al hemisferio norte: porqué una de las pandemias más benignas de la historia, está costando millones de dolares a los gobiernos, y ha generado un pánico sin precedentes? No fue escrito en un sitio de salud, sino en uno más vinculado a economia y finanzas, y creemos vale la pena prestarle atención.
Lo pueden leer desde aqui. http://knol.google.com/k/ruben-roa/mr-flu-acusado-de-graves-conflictos-de/2lyuwoedvc3qb/6

12 diciembre, 2009

Taken from "1918 Influenza: the Mother of...Image via Wikipedia

H1N1 less lethal than feared: U.K. study

Last Updated: Thursday, December 10, 2009 | 3:34 PM ET Comments285Recommend89

Medical advances such as ventilators and intensive care were not available during previous pandemics. Medical advances such as ventilators and intensive care were not available during previous pandemics. (CBC)The strain of swine flu virus currently circulating around the world is less deadly than previously thought, say British scientists who compared its effect to that of other pandemic viruses.
The 2009 flu pandemic is about 100 times less lethal than the 1918 Spanish flu and nearly 10 times less fatal than the flu pandemics of 1957 and 1968.
Those findings were reported in Thursday's online issue of British Medical Journal, BMJ.
After analyzing British health department data on all reported swine flu patients who were hospitalized between July and Nov. 8 , the researchers estimated that about 26 of every 100,000 people infected with the H1N1 influenza A virus that causes swine flu died. That is a death rate of 0.026 per cent.
The findings are similar to a U.S. study published on Monday that estimated the death rate in the current swine flu pandemic is 0.048 per cent, or one death per every 2,000 cases.
"The first influenza pandemic of the 21st century is considerably less lethal than was feared in advance," England's chief medical officer, Liam Donaldson, and his co-authors from Britain's Health Protection Agency wrote in the study.
In comparison, the fatality rate for the 1918 Spanish flu pandemic was two to three per cent, compared with around 0.2 per cent for the pandemics in 1957-1958 and 1967-1968. Fatality estimates for previous pandemics were probably less reliable since they were based on statistical methods and death certificates, with few — if any — lab confirmations.
Since the past pandemics, there have been advances in medicine such as ventilators to help patients with breathing problems, as well as better housing, health care and nutrition, Donaldson said.
When the World Health Organization declared swine flu had reached a pandemic stage in June, the agency described it as "moderate," with most people infected showing mild symptoms and recovering without medical treatment.
A pandemic designation reflects how widely a virus has spread, not the severity of illness.

Findings not a reason for inaction

Donaldson's study suggested two-thirds of those who died from H1N1 would be eligible for the H1N1 vaccine under the British government's plan, which prioritizes those at highest risk of developing complications from the flu.
This includes patients sick in hospital, pregnant women, people with asthma or other underlying health problems and health care workers.
"Viewed statistically, mortality in this pandemic compares favourably with 20th century influenza pandemics. A lower population impact than previous pandemics, however, is not a justification for public health inaction," the study's authors concluded. "Our data support the priority vaccination of high-risk groups."
Some of the deaths, 38 per cent, occurred in people not considered at high risk.
The findings also reinforced calls to prescribe antiviral medications for people at high risk or those showing severe symptoms.
Most of the people who died of swine flu in Britain, 78 per cent, had been prescribed antiviral drugs. But of these, 76 per cent did not received them within the first 48 hours of illness as recommended.

Infection rate higher among native populations

Also on Thursday, U.S. health officials said an estimated 15 per cent of Americans had been infected with the H1N1 virus by mid November.
In its weekly report on death and disease, the U.S. Centers for Disease Control and Prevention (CDC) suggested the death rate among the aboriginal population in the U.S. is about four times higher than that of all other racial and ethnic groups combined.
Similarly, indigenous populations in Australia, Canada and New Zealand have been found to have a three to eight times higher rate of hospitalization and death associated with swine flu.
There is a lot of debate about why the rates are higher among aboriginal populations, but it likely reflects environmental conditions such as nutrition in early childhood, access to health care and the a higher likelihood of un
Reblog this post [with Zemanta]